Nüesch, R. and Ananworanich, J. and Srasuebkul, P. and Chetchotisakd, P. and Prasithsirikul, W. and Klinbuayam, W. and Mahanontharit, A. and Jupimai, T. and Ruxrungtham, K. and Hirschel, B.. (2008) Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. AIDS, Vol. 22. pp. 152-154.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6004956
Downloads: Statistics Overview
Abstract
Thai patients enrolled in STACCATO with HIV/hepatitis B virus (HBV) co-infection and tenofovir/emtricitabine-based antiretroviral therapy (ART) were randomly assigned to continuous treatment or CD4 cell count-guided interruptions. HBV replication was suppressed below detection in 15/16 patients. Structured treatment interruption increased transaminases and HBV viraemia in five of six patients; one flare was severe. Conversion to anti-hepatitis Be occurred with continuous treatment only. Tenofovir/emtricitabine-containing ART is highly effective in controlling chronic HIV/HBV co-infection but treatment should not be interrupted.
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Allgemeine innere Medizin USB > Ambulante innere Medizin (Hess C) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Allgemeine innere Medizin USB > Ambulante innere Medizin (Hess C) |
|---|---|
| UniBasel Contributors: | Nüesch, Reto |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Current Science |
| ISSN: | 0269-9370 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Related URLs: | |
| Identification Number: |
|
| Last Modified: | 08 Nov 2012 16:22 |
| Deposited On: | 08 Nov 2012 16:09 |
Repository Staff Only: item control page